Genzyme (NASDAQ: GENZ - option chain) shares are headed higher today after the company reported a fourth-quarter profit this morning of $1.04 per share on revenue of $1.17 billion, beating analysts' projections of $1.02 per share on revenue of $1.18 billion. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on GENZ.GENZ opened this morning at $72.47. So far today the stock has hit a low of $71.23 and a high of $73.41. As of 11:40, GENZ is trading at $71.95, up 76 cents (1.1%). The chart for GENZ looks bullish and S&P gives GENZ a positive 5 STARS (out of 5) strong buy ranking.
GENZ hasn't been below $60 at all in the past year except for two days in December and has shown support around $68 recently.
Brent Archer is an options analyst and writer at Investors Observer.
DISCLOSURE: Mr. Archer owns and/or controls diversified portfolios of long and short stock and option positions that may include holdings in companies he writes about. At publication time, Brent controls bullish hedged positions in GENZ.










